Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Hin HIn Ko"'
Autor:
Surain B. Roberts, Woo Jin Choi, Lawrence Worobetz, Catherine Vincent, Jennifer A. Flemming, Angela Cheung, Karim Qumosani, Mark Swain, Dusanka Grbic, Hin Hin Ko, Kevork M. Peltekian, Lusine Abrahamyan, Monika Saini, Kattleya Tirona, Bishoi Aziz, Ellina Lytvyak, Pietro Invernizzi, Cyriel Y. Ponsioen, Tony Bruns, Nora Cazzagon, Keith Lindor, George N. Dalekos, Nikolaos K. Gatselis, Xavier Verhelst, Annarosa Floreani, Christophe Corpechot, Marlyn J. Mayo, Cynthia Levy, Maria-Carlota Londoño, Pier M. Battezzati, Albert Pares, Frederik Nevens, Adriaan van der Meer, Kris V. Kowdley, Palak J. Trivedi, Ana Lleo, Douglas Thorburn, Marco Carbone, Nazia Selzner, Aliya F. Gulamhusein, Harry LA. Janssen, Aldo J. Montano-Loza, Andrew L. Mason, Gideon M. Hirschfield, Bettina E. Hansen
Publikováno v:
JHEP Reports, Vol 6, Iss 10, Pp 101168- (2024)
Background & Aims: Biochemical response to ursodeoxycholic acid (UDCA) therapy is associated with good prognosis in people living with primary biliary cholangitis (PBC). Biochemical response is typically assessed early in disease and it is not known
Externí odkaz:
https://doaj.org/article/8d1c44ac78ae4a3ebc2eca8571c39ace
Autor:
Jean Damascene Makuza, Dahn Jeong, Stanley Wong, Mawuena Binka, Prince Asumadu Adu, Héctor Alexander Velásquez García, Richard L. Morrow, Georgine Cua, Amanda Yu, Maria Alvarez, Sofia Bartlett, Hin Hin Ko, Eric M. Yoshida, Alnoor Ramji, Mel Krajden, Naveed Zafar Janjua
Publikováno v:
The Lancet Regional Health. Americas, Vol 36, Iss , Pp 100826- (2024)
Summary: Background: We evaluated the association of hepatitis B virus (HBV) treatment with all-cause, and liver-related mortality among individuals with HBV and cirrhosis in British Columbia (BC), Canada. Methods: This analysis included people diagn
Externí odkaz:
https://doaj.org/article/645343e1635241beb792a883b3708884
Autor:
Hin Hin Ko, Nishi H. Patel, Sarah Haylock-Jacobs, Karen Doucette, Mang M. Ma, Curtis Cooper, Erin Kelly, Magdy Elkhashab, Edward Tam, Robert Bailey, Alexander Wong, Gerald Minuk, Philip Wong, Scott K. Fung, Giada Sebastiani, Alnoor Ramji, Carla S. Coffin
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 1, Pp 106-116 (2022)
Background and Aims: The obesity epidemic has increased the risk of nonalcoholic fatty liver disease (NAFLD) in both the general and chronic hepatitis B (CHB) populations. Our study aims to determine the prevalence of NAFLD in patients with CHB based
Externí odkaz:
https://doaj.org/article/3cf47ef794274f09925c31ab7ba337a5
Publikováno v:
Case Reports in Hepatology, Vol 2023 (2023)
Fanconi syndrome is a rare disease of generalized proximal tubule dysfunction which can be acquired secondary to certain medications, including tenofovir, a commonly used hepatitis B treatment. Signs and symptoms of ensuing renal wasting can be sever
Externí odkaz:
https://doaj.org/article/544408eab8a94b7e8f8f38b7e9916056
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 16, Iss 1, Pp 1-4 (2020)
Abstract Longer time to diagnosis for patients with eosinophilic esophagitis can lead to adverse patient outcomes, but the length of diagnostic delay has not been quantified for patients with eosinophilic esophagitis in Canada. Our study defines the
Externí odkaz:
https://doaj.org/article/25c56be431bc4fb1a8165f0914bce689
Autor:
Carla S. Coffin, Sarah Haylock-Jacobs, Karen Doucette, Alnoor Ramji, Hin Hin Ko, David K. Wong, Magdy Elkhashab, Robert Bailey, Julia Uhanova, Gerald Minuk, Keith Tsoi, Alexander Wong, Mang M. Ma, Edward Tam, Mayur Brahmania, Carmine Nudo, Julie Zhu, Christopher F. Lowe, Carla Osiowy, B. Cord Lethebe, Stephen E. Congly, Eric K. H. Chan, Angelina Villasis-Keever, Urbano Sbarigia, Curtis L. Cooper, Scott Fung
Publikováno v:
Viruses, Vol 14, Iss 12, p 2668 (2022)
Background: Hepatitis B surface antigen (HBsAg) loss is associated with improved clinical outcomes for individuals with chronic hepatitis B (CHB); however, the effects of varying HBsAg levels on clinical outcomes in diverse cohorts are understudied.
Externí odkaz:
https://doaj.org/article/6989dedfa34b460aaecea1e961657d56
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 29, Iss 6, Pp 315-320 (2015)
BACKGROUND: The current treatment rate for chronic hepatitis C virus (HCV) infection is suboptimal despite the availability of efficacious antiviral therapy.
Externí odkaz:
https://doaj.org/article/73d12a92fe304a1b86f10b618936e51e
Autor:
Alan Hoi Lun Yau, George Ou, Cherry Galorport, Jack Amar, Brian Bressler, Fergal Donnellan, Hin Hin Ko, Eric Lam, Robert Allan Enns
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 28, Iss 2, Pp 72-76 (2014)
BACKGROUND: Hemospray (Cook Medical, USA) has recently been approved in Canada for the management of nonvariceal upper gastrointestional bleeding (UGIB).
Externí odkaz:
https://doaj.org/article/7eafbde55e4a473384a0eee427c53580
Publikováno v:
Canadian Journal of Gastroenterology, Vol 25, Iss 8, Pp 445-448 (2011)
Hepatitis C (HCV) infection is prevalent in recipients of, and candidates for, solid organ transplants. The outcomes of HCV infection in cardiac and lung transplant recipients have yet to be clearly established, and future prospective studies are nee
Externí odkaz:
https://doaj.org/article/06a97d1967984b89b29d8a8d90a3feb2
Autor:
Hin Hin Ko, Erica Greanya, Tim K. Lee, Urs P. Steinbrecher, Siegfried R. Erb, Eric M. Yoshida
Publikováno v:
Annals of Hepatology, Vol 7, Iss 4, Pp 376-380 (2008)
Background: Calcineurin inhibitors (CNIs) provide effective immunosuppression after orthotopic liver transplantation (OLTx), but the associated nephrotoxicity can cause substantial morbidity and mortality among transplant patients. In this study, we
Externí odkaz:
https://doaj.org/article/ea8980f3ac4b47a9aa76095cd73e8225